Compare Stocks: NNOX, SMTI, FOCL, and OBIO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$6.13 +0.2%	$5.24	$1.21 ▼ $6.36	$229.77M	-0.04	52,925 shs	10,479 shs
NNOX Nano-X Imaging	$1.09 +10.7%	$1.41	$0.73 ▼ $4.95	$75.87M	1.24	1.60 million shs	139,751 shs
OBIO Orchestra BioMed	$4.08 +2.4%	$3.95	$2.20 ▼ $5.42	$244.91M	0.49	255,229 shs	10,206 shs
SMTI Sanara MedTech	$34.21 +1.0%	$24.06	$16.05 ▼ $35.95	$313.50M	1.18	87,479 shs	67,642 shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	0.00%	+1.49%	+18.15%	+611,999,900.00%	+611,999,900.00%
NNOX Nano-X Imaging	0.00%	+9.34%	-24.62%	-43.36%	-78.70%
OBIO Orchestra BioMed	0.00%	+6.42%	-5.01%	+0.25%	+63.11%
SMTI Sanara MedTech	0.00%	+32.47%	+36.31%	+71.62%	+40.15%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$6.13 +0.2%	$5.24	$1.21 ▼ $6.36	$229.77M	-0.04	52,925 shs	10,479 shs
NNOX Nano-X Imaging	$1.09 +10.7%	$1.41	$0.73 ▼ $4.95	$75.87M	1.24	1.60 million shs	139,751 shs
OBIO Orchestra BioMed	$4.08 +2.4%	$3.95	$2.20 ▼ $5.42	$244.91M	0.49	255,229 shs	10,206 shs
SMTI Sanara MedTech	$34.21 +1.0%	$24.06	$16.05 ▼ $35.95	$313.50M	1.18	87,479 shs	67,642 shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	0.00%	+1.49%	+18.15%	+611,999,900.00%	+611,999,900.00%
NNOX Nano-X Imaging	0.00%	+9.34%	-24.62%	-43.36%	-78.70%
OBIO Orchestra BioMed	0.00%	+6.42%	-5.01%	+0.25%	+63.11%
SMTI Sanara MedTech	0.00%	+32.47%	+36.31%	+71.62%	+40.15%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FOCL FocalTherics	2.50	Moderate Buy	$9.00	46.82% Upside
NNOX Nano-X Imaging	2.67	Moderate Buy	$4.00	268.66% Upside
OBIO Orchestra BioMed	2.57	Moderate Buy	$13.60	233.66% Upside
SMTI Sanara MedTech	2.20	Hold	$35.00	2.31% Upside

Current Analyst Ratings Breakdown

Latest NNOX, SMTI, FOCL, and OBIO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2026	SMTI Sanara MedTech	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$35.00
7/30/2026	SMTI Sanara MedTech	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$36.00 ➝ $35.00
7/17/2026	OBIO Orchestra BioMed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	SMTI Sanara MedTech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	FOCL FocalTherics	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform	$15.00
7/17/2026	FOCL FocalTherics	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
7/8/2026	NNOX Nano-X Imaging	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/7/2026	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$5.00 ➝ $3.00
6/22/2026	NNOX Nano-X Imaging	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
6/17/2026	SMTI Sanara MedTech	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
6/10/2026	SMTI Sanara MedTech	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FOCL FocalTherics	$74.07M	3.10	N/A	N/A	$0.52 per share	11.79
NNOX Nano-X Imaging	$14.52M	5.20	N/A	N/A	$2.01 per share	0.54
OBIO Orchestra BioMed	$32.72M	7.46	N/A	N/A	$0.95 per share	4.29
SMTI Sanara MedTech	$107.48M	2.92	$0.60 per share	56.95	$0.67 per share	51.06

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FOCL FocalTherics	-$29.25M	-$0.81	N/A	N/A	N/A	-41.47%	-137.61%	-40.62%	8/27/2026 (Estimated)
NNOX Nano-X Imaging	-$75.02M	-$1.58	N/A	N/A	N/A	-716.44%	-70.96%	-62.26%	8/11/2026 (Estimated)
OBIO Orchestra BioMed	-$52.70M	-$0.97	N/A	N/A	N/A	-166.96%	-157.46%	-60.18%	8/11/2026 (Estimated)
SMTI Sanara MedTech	-$37.56M	-$3.77	N/A	N/A	N/A	-31.23%	-3.19%	-0.56%	8/12/2026 (Estimated)

Latest NNOX, SMTI, FOCL, and OBIO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/27/2026	Q2 2026	FOCL FocalTherics	-$0.2287	N/A	N/A	N/A	$22.48 million	N/A
8/12/2026	Q2 2026	SMTI Sanara MedTech	-$0.0250	N/A	N/A	N/A	$28.95 million	N/A
8/11/2026	N/A	NNOX Nano-X Imaging	-$0.1633	N/A	N/A	N/A	$5.39 million	N/A
8/11/2026	Q2 2026	OBIO Orchestra BioMed	-$0.35	N/A	N/A	N/A	$0.14 million	N/A
6/25/2026	Q1 2026	NNOX Nano-X Imaging	N/A	-$0.16	N/A	-$0.20	N/A	$4.31 million
5/12/2026	Q1 2026	OBIO Orchestra BioMed	-$0.40	-$0.33	+$0.07	-$0.33	$0.92 million	$0.11 million
5/7/2026	Q1 2026	FOCL FocalTherics	-$0.22	-$0.24	-$0.02	-$0.24	$19.46 million	$20.48 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FOCL FocalTherics	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
OBIO Orchestra BioMed	N/A	N/A	N/A	N/A	N/A
SMTI Sanara MedTech	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FOCL FocalTherics	1.79	1.34	0.99
NNOX Nano-X Imaging	N/A	3.64	3.40
OBIO Orchestra BioMed	0.35	7.03	7.01
SMTI Sanara MedTech	6.59	2.28	2.05

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FOCL FocalTherics	62.74%
NNOX Nano-X Imaging	21.49%
OBIO Orchestra BioMed	53.20%
SMTI Sanara MedTech	8.10%

Insider Ownership

Company	Insider Ownership
FOCL FocalTherics	10.10%
NNOX Nano-X Imaging	7.74%
OBIO Orchestra BioMed	7.50%
SMTI Sanara MedTech	42.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FOCL FocalTherics	230	37.48 million	33.70 million	N/A
NNOX Nano-X Imaging	190	69.60 million	N/A	Optionable
OBIO Orchestra BioMed	4	59.88 million	55.39 million	Not Optionable
SMTI Sanara MedTech	60	9.16 million	5.32 million	Not Optionable

NNOX, SMTI, FOCL, and OBIO Headlines

Recent News About These Companies

Sanara MedTech (NASDAQ:SMTI) Cut to Neutral at HC Wainwright

August 2 at 1:48 AM | americanbankingnews.com

Wall Street Zen Downgrades Sanara MedTech (NASDAQ:SMTI) to Buy

August 1 at 1:12 AM | americanbankingnews.com

Sanara MedTech (NASDAQ:SMTI) Downgraded by Wall Street Zen to Buy

August 1 at 1:11 AM | marketbeat.com

MiMedx to acquire Sanara MedTech for $350M

July 31 at 3:03 AM | massdevice.com

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)

July 30, 2026 | prnewswire.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)

July 30, 2026 | globenewswire.com

Sanara MedTech (NASDAQ:SMTI) Downgraded to Neutral Rating by HC Wainwright

July 30, 2026 | marketbeat.com

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders

July 30, 2026 | prnewswire.com

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

July 30, 2026 | aol.comA

MiMedx agrees to buy Sanara MedTech for $35 a share

July 30, 2026 | msn.com

Sanara MedTech agrees to be acquired by MiMedx

July 29, 2026 | tipranks.com

MIMEDX to Acquire Sanara MedTech

July 29, 2026 | globenewswire.com

Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

July 13, 2026 | marketbeat.com

Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth

June 23, 2026 | finance.yahoo.com

Sanara MedTech Earnings Call Signals Profitable Growth

June 12, 2026 | theglobeandmail.com

Sanara MedTech (SMTI) Q1 2026 Earnings Transcript

June 2, 2026 | fool.com

How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put

May 23, 2026 | finance.yahoo.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

May 21, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

May 19, 2026 | globenewswire.com

Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

May 14, 2026 | finance.yahoo.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

May 14, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX, SMTI, FOCL, and OBIO Company Descriptions

FocalTherics NASDAQ:FOCL

$6.13 +0.01 (+0.16%)

As of 09:50 AM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Nano-X Imaging NASDAQ:NNOX

$1.08 +0.11 (+10.73%)

As of 10:07 AM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Orchestra BioMed NASDAQ:OBIO

$4.08 +0.10 (+2.41%)

As of 10:07 AM Eastern

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Sanara MedTech NASDAQ:SMTI

$34.21 +0.35 (+1.03%)

As of 10:07 AM Eastern

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, SMTI, FOCL, and OBIO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, SMTI, FOCL, and OBIO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, SMTI, FOCL, and OBIO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX, SMTI, FOCL, and OBIO Company Descriptions

FocalTherics NASDAQ:FOCL

Nano-X Imaging NASDAQ:NNOX

Orchestra BioMed NASDAQ:OBIO

Sanara MedTech NASDAQ:SMTI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, SMTI, FOCL, and OBIO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, SMTI, FOCL, and OBIO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, SMTI, FOCL, and OBIO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX, SMTI, FOCL, and OBIO Company Descriptions

FocalTherics NASDAQ:FOCL

Nano-X Imaging NASDAQ:NNOX

Orchestra BioMed NASDAQ:OBIO

Sanara MedTech NASDAQ:SMTI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools